Answers are grounded in this paper and cite their sources.
Despite widespread endorsement, Teppo Järvinen and colleagues argue that evidence for stratifying risk of fracture and subsequent drug therapy to prevent hip fracture is insufficient to warrant our current approach
No takes yet. Share an insight, caveat, or question.
Järvinen et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: